CNCE stock forecast
Our latest prediction for Concert Pharmaceuticals Inc - CNCE's stock price was made on the Feb. 21, 2023 when the stock price was at 8.35$.
In the short term (2weeks), CNCE's stock price should underperform the market by -2.63%. During that period the price should oscillate between -10.16% and +7.61%.
In the medium term (3months), CNCE's stock price should underperform the market by -15.54%. During that period the price should oscillate between -27.84% and +18.59%.
Get email alertsCreate a solid portfolio with CNCE
About Concert Pharmaceuticals Inc - CNCE
At the moment the company generates 102M USD in revenues.
On its last earning announcement, the company reported a loss of -2.98$ per share.
The book value per share is 8.55$
Three months stock forecastFeb. 21, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102M | 0.04% | -124M | -120.94% | -91M | -2.98 | - | - | 47M | 8.55 | - | - | - |